Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis

International Journal of Immunogenetics

Volumn 36, Issue 2, 2009, Pages 103-106

  Sahin, M ^a,b   Gursoy, A ^b   Erdogan, M F ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GOITER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THYROID HORMONE BLOOD LEVEL; TURKEY (REPUBLIC);

ADULT; ALLELES; ANTIGENS, CD; FEMALE; GENE FREQUENCY; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; TURKEY;

EID: 61849094915     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00831.x     Document Type: Article

References (20)

1. Chambers, C.A., Krummel, M.F., Boitel, B., Hurwitz, A., Sullivan, T.J., Fournier, S., Cassell, D., Brunner, M. Allison, J.P. (1996) The role of CTLA-4 in the regulation of T-cell responses. Immunological Reviews, 153, 27.
2. Chistiakov, D.A. Turakulov, R.I. (2003) CTLA-4 and its role in autoimmune thyroid disease. Journal of Molecular Endocrinology, 31, 21.
3. Chistyakov, D.A., Savost'anov, K.V., Turakulov, R.I., Petunina, N.A., Trukhina, L.V., Kudinova, A.V., Balabolkin, M.I. Nosikov, V.V. (2000) Complex association analysis of Graves' disease using a set of polymorphic markers. Molecular Genetics and Metabolism, 70, 214.
4. Donner, H., Rau, H., Walfish, P.G., Braun, J., Siegmund, T., Finke, R., Herwig, J., Usadel, K.H. Badenhoop, K. (1997) CTLA 4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 82, 143.
5. Heward, J.M., Allahabadia, A., Armitage, M., Hattersley, A., Dodson, P.M., Macleod, K. et al 1999) The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. Journal of Clinical Endocrinology and Metabolism, 84, 2398.
6. Kavvoura, F.K., Akamizu, T., Awata, T., Ban, Y., Chistiakov, D.A., Frydecka, I. et al 2007 August) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 92 : 3162.
7. Kouki, T., Gardine, C.A., Yanagawa, T. Degroot, L.J. (2002) Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. Journal of Endocrinological Investigation, 25, 208.
8. Mäurer, M., Loserth, S., Kolb-Maurer, A., Ponath, A., Wiese, S., Kruse, N. Rieckmann, P. (2002) Apolymorphism in human cytotoxic T lymphocyte antigen 4 (CTLA-4) gene (exon 1 +49) alters T cell activation. Immunogenetics, 54, 1.
9. Oosterwegel, M.A., Greenwald, R.J., Mandelbrot, D.A., Lorsbach, R.B. Sharpe, A.H. (1999) CTLA-4 and T cell activation. Current Opinion in Immunology, 11, 294.
10. Petrone, A., Giorgi, G., Mesturino, C.A., Capizzi, M., Cascino, I., Nistico, L., Osborn, J., Di Mario, U. Buzzetti, R. (2001) Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid, 11, 171.
11. Sahin, M., Erdogan, M.F. Erdogan, G. (2005) Cytotoxic T lymphocyte-associated molecule-4 polymorphisms in Turkish Graves' disease patients and association with probability of remission after antithyroid therapy. European Journal of Internal Medicine, 16, 352.
12. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A. Sharpe, A.H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction: revealing a critical negative regulatory role of CTLA-4. Immunity, 3, 541.
13. Tivol, E.A., Schweitzer, A.N. Sharpe, A.H. (1996) Costimulation and autoimmunity. Current Opinion in Immunology, 8, 822.
14. Tomer, Y., Greenberg, D.A., Barbesino, G., Concepcion, E. Davies, T.F. (2001) CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. Journal of Clinical Endocrinology and Metabolism, 86, 1687.
15. Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G. et al 2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506.
16. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Greene, J.M., Thompson, C.B. Bluestone, J.A. (1994) CTLA-4 can function as a negative regulator of T-cell activation. Immunity, 1, 405.
17. Wang, C. Crapo, L.M. (1997) The epidemiology of thyroid disease and implications for screening. Endocrinology and Metabolism Clinics of North America, 26, 189.
18. Yanagawa, T., Hidaka, Y., Guimaraes, V., Soliman, M. DeGroot, L. J. (1995) CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. Journal of Clinical Endocrinology and Metabolism, 80, 41.
19. Yanagawa, T., Taniyama, M., Enomoto, S., Gomi, K., Maruyama, H., Ban, Y. Saruta, T. (1997) CTLA 4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid, 7, 843.
20. Zeitlin, A.A., Heward, J.M., Newby, P.R., Carr-Smith, J.D., Franklyn, J.A., Gough, S.C. Simmonds, M.J. (2008 June) Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes and Immunity, 9, 358.